Gene therapy-mediated enhancement of protective protein expression for the treatment of Alzheimer’s disease
- 7 January 2021
- journal article
- review article
- Published by Elsevier BV in Brain Research
- Vol. 1753, 147264
- https://doi.org/10.1016/j.brainres.2020.147264
Abstract
No abstract availableKeywords
This publication has 210 references indexed in Scilit:
- AAV serotype 2/1-mediated gene delivery of anti-inflammatory interleukin-10 enhances neurogenesis and cognitive function in APP+PS1 miceGene Therapy, 2011
- Prion protein and Aβ‐related synaptic toxicity impairmentEMBO Molecular Medicine, 2010
- The Spectrum of Mutations in ProgranulinArchives of Neurology, 2010
- Neuropathology of Alzheimer's DiseaseMount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2010
- An Overview of APP Processing Enzymes and ProductsNeuroMolecular Medicine, 2009
- From Promiscuity to Precision: Protein Phosphatases Get a MakeoverMolecular Cell, 2009
- Therapeutic potential of CERE-110 (AAV2-NGF): Targeted, stable, and sustained NGF delivery and trophic activity on rodent basal forebrain cholinergic neuronsExperimental Neurology, 2008
- Redox Reactions of Copper Complexes Formed with Different β-Amyloid Peptides and Their Neuropathalogical RelevanceBiochemistry, 2007
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991
- Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's diseaseNature, 1991